Filing Details
- Accession Number:
- 0001104659-11-006516
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-10 12:00:00
- Reporting Period:
- 2011-02-08
- Filing Date:
- 2011-02-10
- Accepted Time:
- 2011-02-10 20:35:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1396814 | Pacira Pharmaceuticals Inc. | PCRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1232258 | Ltd Cayman Bioventures Hbm | Centennial Towers, 3Rd Floor 2454 West Bay Road Grand Cayman, Cayman Islands | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-02-08 | 1,487,680 | $0.00 | 1,580,660 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2011-02-08 | 1,021,223 | $13.44 | 2,601,883 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2011-02-08 | 267,857 | $7.00 | 2,869,740 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2011-02-08 | 267,857 | $7.00 | 3,137,597 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | C | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Convertible Stock | Disposition | 2011-02-08 | 1,487,680 | $0.00 | 1,487,680 | $0.00 |
Common Stock | Convertible Promissory Note | Disposition | 2011-02-08 | 1,021,223 | $0.00 | 1,021,223 | $13.44 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Represents shares of Common Stock acquired upon the automatic conversion of Series A convertible preferred stock upon the closing of the Issuer's initial public offering of Common Stock.
- The Series A convertible preferred stock did not have an expiration date. The Series A convertible preferred stock automatically converted into shares of Common Stock at an effective conversion ratio of one-to-one upon the closing of the Issuer's initial public offering of Common Stock.
- Represents shares of Common Stock acquired upon the automatic conversion of all principal and accrued interest due on these convertible promissory notes upon the closing of the Issuer's initial public offering of Common Stock at an effective conversion price of approximately $13.44.
- These shares of Common Stock were acquired upon conversion of a convertible promissory note exempt from the definition of a derivative security because the conversion price of such securities did not become fixed until their automatic conversion at the time of closing of the Issuer's initial public offering of Common Stock.
- Represents shares of Common Stock acquired upon the conversion of a convertible promissory note issued in December 2010. The outstanding principal amount and accrued but unpaid interest therein was automatically converted into shares of Common Stock upon the closing of the Issuer's initial public offering of Common Stock at an effective conversion price of $7.00 which represents the initial public offering price per share of the Common Stock sold by the issuer..